DCM
IRMD icon

Dupont Capital Management’s iRadimed IRMD Stock Holding History

Dupont Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,123
Closed -$94K – 1473
2022
Q3 		$94K Sell
3,123
-7,443
-70% -$259K 0.01% 1062
2022
Q2 		$359K Buy
+10,566
New +$379K 0.02% 824
2019
Q2 		– Sell
-14,876
Closed -$418K – 1236
2019
Q1 		$418K Hold
14,876
– – 0.01% 831
2018
Q4 		$364K Buy
+14,876
New +$400K 0.01% 838

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dupont Capital Management's IRMD Position: Q4 2022 in Review

Dupont Capital Management sold out of iRadimed (IRMD) in Q4 2022, closing a stake of 3,123 shares — an estimated $94K sold.

Dupont Capital Management first reported a position in IRMD in Q4 2018 and held it in 4 quarters. The position peaked at $418K in Q1 2019. 79 funds tracked by Wall St. Rank hold IRMD as of Q4 2022.

  • Dupont Capital Management reported no remaining iRadimed position as of Q4 2022 after selling out during the quarter.
  • Dupont Capital Management sold 3,123 iRadimed shares in Q4 2022, an estimated $94K.
  • Dupont Capital Management first reported a position in iRadimed in Q4 2018 and held it in 4 quarters.
  • Dupont Capital Management's iRadimed position peaked at $418K in Q1 2019.
  • 79 funds tracked by Wall St. Rank held iRadimed as of Q4 2022.

Based on Dupont Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.